Logos Global Management LP Incresed Positions in Q3 2024

Logos Global Management LP

  • $756 Million
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
ERAS
Erasca, Inc.

Healthcare
5M
+ 84.75%
$2.17 - $3.28 $10.9M - $16.4M
10.9M $29.8M
IONS
Ionis Pharmaceuticals Inc

Healthcare
450K
+ 150.0%
$40.06 - $51.86 $18M - $23.3M
750K $30M
IMVT
Immunovant, Inc.

Healthcare
525K
+ 91.3%
$27.51 - $27.51 $14.4M - $14.4M
1.1M $30.3M
JANX
Janux Therapeutics, Inc.

Healthcare
250K
+ 33.33%
$35.29 - $50.26 $8.82M - $12.6M
1M $45.4M
IDYA
Ideaya Biosciences, Inc.

Healthcare
400K
+ 23.53%
$30.37 - $43.05 $12.1M - $17.2M
2.1M $66.5M
UNCY
Unicycive Therapeutics, Inc.

Healthcare
1.61M
+ 46.37%
$0.24 - $0.54 $386K - $869K
5.08M $2.08M
Disc Medicine Inc
10K
+ 1.08%
N/A
935K $0
Structure Therapeutics Inc
150K
+ 13.64%
N/A
1.25M $0
LCTX
Lineage Cell Therapeutics, Inc.

Healthcare
300K
+ 6.38%
$0.8 - $1.12 $240K - $336K
5M $4.55M
Activity Summary
Buys All Purchases 24 New Holdings 15 Increased Positions 9 Sells All Sells 17 Reductions 17 Sold out 0 Options Calls 1 Puts 0
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email